| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |